Peking University Third Hospital: Coronary Artery Disease trials
The registry lists 10 Coronary Artery Disease studies with Peking University Third Hospital as lead sponsor. 4 are open to participants now and 0 have results posted.
Phase 4 2No phase 8(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- A Randomized Controlled Trial: Fuzheng Yangxin Formula for ERAS After CABGNot yet recruitingNCT07781436Not applicable
- Effect of Secukinumab on Cardiorenal Outcomes in Patients With Cardiorenal Metabolic Syndrome and Atherosclerotic Cardiovascular DiseaseNot yet recruitingNCT07704190Phase 4
- Influencing Factors of the Diagnostic Accuracy of Novel Coronary Functional Evaluation MethodsNot yet recruitingNCT06178133
- Comparative Clinical Study of Drug-coating Balloon Strategy and Drug-eluting Stent StrategyNot yet recruitingNCT04842838Not applicable
- The Effect of Nicorandil on Left Ventricular Myocardial Strain in Patients With Coronary Chronic Total OcclusionCompletedNCT05087797Phase 4
- Exercise Adherence in Home-based Cardiac RehabilitationStatus unknownNCT04970979
- Exercise Adherence of Home-based Cardiac RehabilitationCompletedNCT04961606
- The Evaluation of Left Ventricular Systolic Function in Different Types of Ischemic Heart DiseaseCompletedNCT04959357
- Peking University & University of Michigan Study of MI and AtherosclerosisCompletedNCT04950699
- Peking and Rotterdam on Mission to Reduce Coronary Artery DiseaseStatus unknownNCT01653119Not applicable